Global Biosimilar Monoclonal Antibodies Market Growth 2023-2028

Report ID: 1162196 | Published Date: Jan 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Biosimilar Monoclonal Antibodies Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Biosimilar Monoclonal Antibodies by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Biosimilar Monoclonal Antibodies by Country/Region, 2017, 2022 & 2028
    2.2 Biosimilar Monoclonal Antibodies Segment by Type
        2.2.1 Infliximab
        2.2.2 Rituximab
        2.2.3 Trastuzumab
        2.2.4 Adalimumab
        2.2.5 Other
    2.3 Biosimilar Monoclonal Antibodies Sales by Type
        2.3.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
        2.3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Type (2017-2022)
    2.4 Biosimilar Monoclonal Antibodies Segment by Application
        2.4.1 Oncology
        2.4.2 Autoimmune Disease
        2.4.3 Other
    2.5 Biosimilar Monoclonal Antibodies Sales by Application
        2.5.1 Global Biosimilar Monoclonal Antibodies Sale Market Share by Application (2017-2022)
        2.5.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Biosimilar Monoclonal Antibodies Sale Price by Application (2017-2022)
3 Global Biosimilar Monoclonal Antibodies by Company
    3.1 Global Biosimilar Monoclonal Antibodies Breakdown Data by Company
        3.1.1 Global Biosimilar Monoclonal Antibodies Annual Sales by Company (2020-2022)
        3.1.2 Global Biosimilar Monoclonal Antibodies Sales Market Share by Company (2020-2022)
    3.2 Global Biosimilar Monoclonal Antibodies Annual Revenue by Company (2020-2022)
        3.2.1 Global Biosimilar Monoclonal Antibodies Revenue by Company (2020-2022)
        3.2.2 Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2020-2022)
    3.3 Global Biosimilar Monoclonal Antibodies Sale Price by Company
    3.4 Key Manufacturers Biosimilar Monoclonal Antibodies Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Biosimilar Monoclonal Antibodies Product Location Distribution
        3.4.2 Players Biosimilar Monoclonal Antibodies Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biosimilar Monoclonal Antibodies by Geographic Region
    4.1 World Historic Biosimilar Monoclonal Antibodies Market Size by Geographic Region (2017-2022)
        4.1.1 Global Biosimilar Monoclonal Antibodies Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Biosimilar Monoclonal Antibodies Annual Revenue by Geographic Region
    4.2 World Historic Biosimilar Monoclonal Antibodies Market Size by Country/Region (2017-2022)
        4.2.1 Global Biosimilar Monoclonal Antibodies Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Biosimilar Monoclonal Antibodies Annual Revenue by Country/Region
    4.3 Americas Biosimilar Monoclonal Antibodies Sales Growth
    4.4 APAC Biosimilar Monoclonal Antibodies Sales Growth
    4.5 Europe Biosimilar Monoclonal Antibodies Sales Growth
    4.6 Middle East & Africa Biosimilar Monoclonal Antibodies Sales Growth
5 Americas
    5.1 Americas Biosimilar Monoclonal Antibodies Sales by Country
        5.1.1 Americas Biosimilar Monoclonal Antibodies Sales by Country (2017-2022)
        5.1.2 Americas Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022)
    5.2 Americas Biosimilar Monoclonal Antibodies Sales by Type
    5.3 Americas Biosimilar Monoclonal Antibodies Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Biosimilar Monoclonal Antibodies Sales by Region
        6.1.1 APAC Biosimilar Monoclonal Antibodies Sales by Region (2017-2022)
        6.1.2 APAC Biosimilar Monoclonal Antibodies Revenue by Region (2017-2022)
    6.2 APAC Biosimilar Monoclonal Antibodies Sales by Type
    6.3 APAC Biosimilar Monoclonal Antibodies Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Biosimilar Monoclonal Antibodies by Country
        7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Country (2017-2022)
        7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022)
    7.2 Europe Biosimilar Monoclonal Antibodies Sales by Type
    7.3 Europe Biosimilar Monoclonal Antibodies Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Biosimilar Monoclonal Antibodies by Country
        8.1.1 Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022)
    8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Type
    8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies
    10.3 Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    10.4 Industry Chain Structure of Biosimilar Monoclonal Antibodies
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Biosimilar Monoclonal Antibodies Distributors
    11.3 Biosimilar Monoclonal Antibodies Customer
12 World Forecast Review for Biosimilar Monoclonal Antibodies by Geographic Region
    12.1 Global Biosimilar Monoclonal Antibodies Market Size Forecast by Region
        12.1.1 Global Biosimilar Monoclonal Antibodies Forecast by Region (2023-2028)
        12.1.2 Global Biosimilar Monoclonal Antibodies Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Biosimilar Monoclonal Antibodies Forecast by Type
    12.7 Global Biosimilar Monoclonal Antibodies Forecast by Application
13 Key Players Analysis
    13.1 Celltrion
        13.1.1 Celltrion Company Information
        13.1.2 Celltrion Biosimilar Monoclonal Antibodies Product Offered
        13.1.3 Celltrion Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Celltrion Main Business Overview
        13.1.5 Celltrion Latest Developments
    13.2 Pfizer (Hospira)
        13.2.1 Pfizer (Hospira) Company Information
        13.2.2 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Offered
        13.2.3 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Pfizer (Hospira) Main Business Overview
        13.2.5 Pfizer (Hospira) Latest Developments
    13.3 3SBIO
        13.3.1 3SBIO Company Information
        13.3.2 3SBIO Biosimilar Monoclonal Antibodies Product Offered
        13.3.3 3SBIO Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 3SBIO Main Business Overview
        13.3.5 3SBIO Latest Developments
    13.4 Novartis (Sandoz)
        13.4.1 Novartis (Sandoz) Company Information
        13.4.2 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Offered
        13.4.3 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Novartis (Sandoz) Main Business Overview
        13.4.5 Novartis (Sandoz) Latest Developments
    13.5 Dr Reddy’s
        13.5.1 Dr Reddy’s Company Information
        13.5.2 Dr Reddy’s Biosimilar Monoclonal Antibodies Product Offered
        13.5.3 Dr Reddy’s Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Dr Reddy’s Main Business Overview
        13.5.5 Dr Reddy’s Latest Developments
    13.6 Celgen Biopharma
        13.6.1 Celgen Biopharma Company Information
        13.6.2 Celgen Biopharma Biosimilar Monoclonal Antibodies Product Offered
        13.6.3 Celgen Biopharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Celgen Biopharma Main Business Overview
        13.6.5 Celgen Biopharma Latest Developments
    13.7 Cadila Healthcare
        13.7.1 Cadila Healthcare Company Information
        13.7.2 Cadila Healthcare Biosimilar Monoclonal Antibodies Product Offered
        13.7.3 Cadila Healthcare Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Cadila Healthcare Main Business Overview
        13.7.5 Cadila Healthcare Latest Developments
    13.8 Hisun Pharma
        13.8.1 Hisun Pharma Company Information
        13.8.2 Hisun Pharma Biosimilar Monoclonal Antibodies Product Offered
        13.8.3 Hisun Pharma Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Hisun Pharma Main Business Overview
        13.8.5 Hisun Pharma Latest Developments
    13.9 Torrent Pharmaceuticals
        13.9.1 Torrent Pharmaceuticals Company Information
        13.9.2 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Offered
        13.9.3 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Torrent Pharmaceuticals Main Business Overview
        13.9.5 Torrent Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Biosimilar Monoclonal Antibodies Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Biosimilar Monoclonal Antibodies Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Infliximab
    Table 4. Major Players of Rituximab
    Table 5. Major Players of Trastuzumab
    Table 6. Major Players of Adalimumab
    Table 7. Major Players of Other
    Table 8. Global Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
    Table 9. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
    Table 10. Global Biosimilar Monoclonal Antibodies Revenue by Type (2017-2022) & ($ million)
    Table 11. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
    Table 12. Global Biosimilar Monoclonal Antibodies Sale Price by Type (2017-2022) & (USD/Unit)
    Table 13. Global Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
    Table 14. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Table 15. Global Biosimilar Monoclonal Antibodies Revenue by Application (2017-2022)
    Table 16. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2017-2022)
    Table 17. Global Biosimilar Monoclonal Antibodies Sale Price by Application (2017-2022) & (USD/Unit)
    Table 18. Global Biosimilar Monoclonal Antibodies Sales by Company (2020-2022) & (K Units)
    Table 19. Global Biosimilar Monoclonal Antibodies Sales Market Share by Company (2020-2022)
    Table 20. Global Biosimilar Monoclonal Antibodies Revenue by Company (2020-2022) ($ Millions)
    Table 21. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company (2020-2022)
    Table 22. Global Biosimilar Monoclonal Antibodies Sale Price by Company (2020-2022) & (USD/Unit)
    Table 23. Key Manufacturers Biosimilar Monoclonal Antibodies Producing Area Distribution and Sales Area
    Table 24. Players Biosimilar Monoclonal Antibodies Products Offered
    Table 25. Biosimilar Monoclonal Antibodies Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 26. New Products and Potential Entrants
    Table 27. Mergers & Acquisitions, Expansion
    Table 28. Global Biosimilar Monoclonal Antibodies Sales by Geographic Region (2017-2022) & (K Units)
    Table 29. Global Biosimilar Monoclonal Antibodies Sales Market Share Geographic Region (2017-2022)
    Table 30. Global Biosimilar Monoclonal Antibodies Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 31. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Geographic Region (2017-2022)
    Table 32. Global Biosimilar Monoclonal Antibodies Sales by Country/Region (2017-2022) & (K Units)
    Table 33. Global Biosimilar Monoclonal Antibodies Sales Market Share by Country/Region (2017-2022)
    Table 34. Global Biosimilar Monoclonal Antibodies Revenue by Country/Region (2017-2022) & ($ millions)
    Table 35. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Country/Region (2017-2022)
    Table 36. Americas Biosimilar Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 37. Americas Biosimilar Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 38. Americas Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022) & ($ Millions)
    Table 39. Americas Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 40. Americas Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
    Table 41. Americas Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
    Table 42. Americas Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
    Table 43. Americas Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Table 44. APAC Biosimilar Monoclonal Antibodies Sales by Region (2017-2022) & (K Units)
    Table 45. APAC Biosimilar Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Table 46. APAC Biosimilar Monoclonal Antibodies Revenue by Region (2017-2022) & ($ Millions)
    Table 47. APAC Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2017-2022)
    Table 48. APAC Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
    Table 49. APAC Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
    Table 50. APAC Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
    Table 51. APAC Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Table 52. Europe Biosimilar Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 53. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 54. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022) & ($ Millions)
    Table 55. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 56. Europe Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
    Table 57. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
    Table 58. Europe Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
    Table 59. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Table 60. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Country (2017-2022) & (K Units)
    Table 61. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2017-2022) & ($ Millions)
    Table 63. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2017-2022)
    Table 64. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Type (2017-2022) & (K Units)
    Table 65. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2017-2022)
    Table 66. Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Application (2017-2022) & (K Units)
    Table 67. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Table 68. Key Market Drivers & Growth Opportunities of Biosimilar Monoclonal Antibodies
    Table 69. Key Market Challenges & Risks of Biosimilar Monoclonal Antibodies
    Table 70. Key Industry Trends of Biosimilar Monoclonal Antibodies
    Table 71. Biosimilar Monoclonal Antibodies Raw Material
    Table 72. Key Suppliers of Raw Materials
    Table 73. Biosimilar Monoclonal Antibodies Distributors List
    Table 74. Biosimilar Monoclonal Antibodies Customer List
    Table 75. Global Biosimilar Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (K Units)
    Table 76. Global Biosimilar Monoclonal Antibodies Sales Market Forecast by Region
    Table 77. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 78. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Americas Biosimilar Monoclonal Antibodies Sales Forecast by Country (2023-2028) & (K Units)
    Table 80. Americas Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 81. APAC Biosimilar Monoclonal Antibodies Sales Forecast by Region (2023-2028) & (K Units)
    Table 82. APAC Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 83. Europe Biosimilar Monoclonal Antibodies Sales Forecast by Country (2023-2028) & (K Units)
    Table 84. Europe Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Forecast by Country (2023-2028) & (K Units)
    Table 86. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 87. Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2023-2028) & (K Units)
    Table 88. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 90. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2023-2028) & (K Units)
    Table 92. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 94. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Celltrion Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 96. Celltrion Biosimilar Monoclonal Antibodies Product Offered
    Table 97. Celltrion Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 98. Celltrion Main Business
    Table 99. Celltrion Latest Developments
    Table 100. Pfizer (Hospira) Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 101. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Product Offered
    Table 102. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 103. Pfizer (Hospira) Main Business
    Table 104. Pfizer (Hospira) Latest Developments
    Table 105. 3SBIO Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 106. 3SBIO Biosimilar Monoclonal Antibodies Product Offered
    Table 107. 3SBIO Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 108. 3SBIO Main Business
    Table 109. 3SBIO Latest Developments
    Table 110. Novartis (Sandoz) Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 111. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Product Offered
    Table 112. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 113. Novartis (Sandoz) Main Business
    Table 114. Novartis (Sandoz) Latest Developments
    Table 115. Dr Reddy’s Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 116. Dr Reddy’s Biosimilar Monoclonal Antibodies Product Offered
    Table 117. Dr Reddy’s Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 118. Dr Reddy’s Main Business
    Table 119. Dr Reddy’s Latest Developments
    Table 120. Celgen Biopharma Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 121. Celgen Biopharma Biosimilar Monoclonal Antibodies Product Offered
    Table 122. Celgen Biopharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 123. Celgen Biopharma Main Business
    Table 124. Celgen Biopharma Latest Developments
    Table 125. Cadila Healthcare Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 126. Cadila Healthcare Biosimilar Monoclonal Antibodies Product Offered
    Table 127. Cadila Healthcare Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 128. Cadila Healthcare Main Business
    Table 129. Cadila Healthcare Latest Developments
    Table 130. Hisun Pharma Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 131. Hisun Pharma Biosimilar Monoclonal Antibodies Product Offered
    Table 132. Hisun Pharma Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 133. Hisun Pharma Main Business
    Table 134. Hisun Pharma Latest Developments
    Table 135. Torrent Pharmaceuticals Basic Information, Biosimilar Monoclonal Antibodies Manufacturing Base, Sales Area and Its Competitors
    Table 136. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Product Offered
    Table 137. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 138. Torrent Pharmaceuticals Main Business
    Table 139. Torrent Pharmaceuticals Latest Developments
List of Figures
    Figure 1. Picture of Biosimilar Monoclonal Antibodies
    Figure 2. Biosimilar Monoclonal Antibodies Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Biosimilar Monoclonal Antibodies Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Biosimilar Monoclonal Antibodies Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Biosimilar Monoclonal Antibodies Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Infliximab
    Figure 10. Product Picture of Rituximab
    Figure 11. Product Picture of Trastuzumab
    Figure 12. Product Picture of Adalimumab
    Figure 13. Product Picture of Other
    Figure 14. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2021
    Figure 15. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2017-2022)
    Figure 16. Biosimilar Monoclonal Antibodies Consumed in Oncology
    Figure 17. Global Biosimilar Monoclonal Antibodies Market: Oncology (2017-2022) & (K Units)
    Figure 18. Biosimilar Monoclonal Antibodies Consumed in Autoimmune Disease
    Figure 19. Global Biosimilar Monoclonal Antibodies Market: Autoimmune Disease (2017-2022) & (K Units)
    Figure 20. Biosimilar Monoclonal Antibodies Consumed in Other
    Figure 21. Global Biosimilar Monoclonal Antibodies Market: Other (2017-2022) & (K Units)
    Figure 22. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2017-2022)
    Figure 23. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application in 2021
    Figure 24. Biosimilar Monoclonal Antibodies Revenue Market by Company in 2021 ($ Million)
    Figure 25. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Company in 2021
    Figure 26. Global Biosimilar Monoclonal Antibodies Sales Market Share by Geographic Region (2017-2022)
    Figure 27. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Geographic Region in 2021
    Figure 28. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2017-2022)
    Figure 29. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Country/Region in 2021
    Figure 30. Americas Biosimilar Monoclonal Antibodies Sales 2017-2022 (K Units)
    Figure 31. Americas Biosimilar Monoclonal Antibodies Revenue 2017-2022 ($ Millions)
    Figure 32. APAC Biosimilar Monoclonal Antibodies Sales 2017-2022 (K Units)
    Figure 33. APAC Biosimilar Monoclonal Antibodies Revenue 2017-2022 ($ Millions)
    Figure 34. Europe Biosimilar Monoclonal Antibodies Sales 2017-2022 (K Units)
    Figure 35. Europe Biosimilar Monoclonal Antibodies Revenue 2017-2022 ($ Millions)
    Figure 36. Middle East & Africa Biosimilar Monoclonal Antibodies Sales 2017-2022 (K Units)
    Figure 37. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue 2017-2022 ($ Millions)
    Figure 38. Americas Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2021
    Figure 39. Americas Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2021
    Figure 40. United States Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Canada Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Mexico Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Brazil Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 44. APAC Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2021
    Figure 45. APAC Biosimilar Monoclonal Antibodies Revenue Market Share by Regions in 2021
    Figure 46. China Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Japan Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 48. South Korea Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Southeast Asia Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 50. India Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Australia Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2021
    Figure 53. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2021
    Figure 54. Germany Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 55. France Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 56. UK Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Italy Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Russia Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2021
    Figure 60. Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2021
    Figure 61. Egypt Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 62. South Africa Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Israel Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Turkey Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 65. GCC Country Biosimilar Monoclonal Antibodies Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Manufacturing Cost Structure Analysis of Biosimilar Monoclonal Antibodies in 2021
    Figure 67. Manufacturing Process Analysis of Biosimilar Monoclonal Antibodies
    Figure 68. Industry Chain Structure of Biosimilar Monoclonal Antibodies
    Figure 69. Channels of Distribution
    Figure 70. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Biosimilar Monoclonal Antibodies Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Biosimilar Monoclonal Antibodies Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Biosimilar Monoclonal Antibodies Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports